TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ +0.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OCS
Line item 2020 2021 2022 2023 2024 2025
– +254.3% -36.2% +208.6% +5.2% +96.3%
– +678.4% -50.7% +327.0% +3.8% +108.9%
– +834.5% -57.2% +93.7% -27.7% +193.9%
– +834.5% -57.2% +363.2% +7.7% +116.1%
– -20.0% +18.2% +638.3% -90.2% +27.9%
– -1,365.3% – – – –
– – – – – –
– +0.0% +39.9% +0.0% +8.9% +0.1%
– +98.2% +13.5% -84.7% +127.7% -15.0%
– -6.4% +195.9% +58.8% +131.7% -16.8%
– +2.7% -26.4% +22.5% +81.0% +59.5%
– +4.3% +369.3% +96.4% -22.7% -69.3%
– +110.3% +7.9% – – –
– – – – -21.7% +167.5%
– – – – – –
– +0.0% +0.0% -8.7% +35.1% +29.6%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?